摘要
目的:观察宁泌泰胶囊联合非那雄胺治疗经尿道前列腺电切术(TURP)后血尿的疗效。方法:选取2016年9月至2017年10月茂名市电白区人民医收治的52例TURP术后血尿患者作为研究对象,按照随机数表法分为观察组与对照组,每组各26例。对照组仅给予非那雄胺治疗,观察组采用非那雄胺联合宁泌泰胶囊治疗。比较两组治疗前及治疗1个月后WBC、分泌型免疫球蛋白A(SIg A)等前列腺液常规检测指标,白细胞介素-1β(IL-1β)、白细胞介素-10(IL-10)等血清炎性因子的变化;比较两组治疗1个月后良性前列腺增生患者生活质量量表(BPHQLS)、治疗效果及药物不良反应发生情况异。结果:治疗1个月后,两组患者前列腺液WBC与SIg A、血清IL-1β与IL-10水平均较治疗前显著下降(均P<0.05),其中观察组低于同期对照组(均P<0.05)。观察组BPHQLS各项评分及总分均高于对照组(均P<0.05);观察组治疗有效率高于对照组(P<0.05)。两组患者药物不良反应发生率比较,差异无统计学意义(P>0.05)。结论:宁泌泰胶囊联合非那雄胺方案对TURP术后血尿治疗效果较为理想,有利于患者预后康复。
Objective: To determine the effect of Ningmitai capsule and Finasteride in the treatment of hematuria after transurethral resection of prostate( TURP). Methods: Fifty-two patients with hematuria after TURP were included as the subjects in the study,and were randomly divided into the study group( n = 26) and control group( n = 26). The control group received the treatment with Finasteride alone,and the study group was treated with Finasteride and Ningmitai capsule. The changes in the routine examination indexes of prostatic fluid[white blood cell count( WBC) and secretory immunoglobulin A( SIg A) ]and serum inflammatory factors[interleukin-1β( IL-1β) and interleukin-10( IL-10) ] were compared between the two groups at the baseline and at 1 month after the treatment. The Qualitfy-of-life Scale for Benign Prostatic Hyperplasia Patient( BPHQLS),efficacy,and occurrence of adverse drug reactions at 1 month after the treatment were compared between the two groups. Results: At 1 month after the treatment,the prostatic fluid WBC and the levels of prostatic fluid SIg A,serum IL-1β and IL-10 in the two groups significantly decreased compared with those at baseline( all P<0.05),and the levels in the study group were significantly lower than those in the contemporary control group( all P<0.05). The item scores and total score of BPHQLS in the study group were higher than those in the control group( all P < 0. 05). The treatment effective rate in the study group was higher than that in the control group( P < 0. 05). There was no statistically significant difference in the incidence of adverse drug reactions between the two groups( P > 0. 05). Conclusion: Ningmitai capsule and Finasteride is ideal for the treatment of hematuria after TURP,which favors the prognosis and rehabilitation of patients.
作者
叶剑辉
Ye Jianhui(Second Department of Surgery,Dianbai District People’s Hospital,Maoming,Guangdong 525400,China)
出处
《广州医科大学学报》
2018年第2期60-63,68,共5页
Academic Journal of Guangzhou Medical University
关键词
宁泌泰胶囊
非那雄胺
前列腺电切术
血尿
Ningmitai capsule
Finasteride
transurethral resection of prostate
hematuria